Debra Odink
2012
In 2012, Debra Odink earned a total compensation of $550.1K as Chief Technology Officer at Anthera Pharmaceuticals, a 12% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $20,468 |
|---|---|
| Option Awards | $156,810 |
| Salary | $327,736 |
| Stock Awards | $45,089 |
| Total | $550,103 |
Odink received $327.7K in salary, accounting for 60% of the total pay in 2012.
Odink also received $20.5K in non-equity incentive plan, $156.8K in option awards and $45.1K in stock awards.
Rankings
In 2012, Debra Odink's compensation ranked 8,439th out of 11,487 executives tracked by ExecPay. In other words, Odink earned more than 26.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,439 out of 11,487 | 27th |
Division Manufacturing | 3,063 out of 4,253 | 28th |
Major group Chemicals And Allied Products | 815 out of 1,203 | 32nd |
Industry group Drugs | 590 out of 925 | 36th |
Industry Pharmaceutical Preparations | 460 out of 700 | 34th |
Source: SEC filing on April 9, 2015.
Odink's colleagues
We found five more compensation records of executives who worked with Debra Odink at Anthera Pharmaceuticals in 2012.
2012
Paul Truex
Anthera Pharmaceuticals
Chief Executive Officer
2012
Colin Hislop
Anthera Pharmaceuticals
Chief Medical Officer
2012
Christopher Lowe
Anthera Pharmaceuticals
Chief Financial Officer
2012
Georgina Kilfoil
Anthera Pharmaceuticals
Senior Vice President, Product Development
2012
May Liu
Anthera Pharmaceuticals